Which hemostatic changes determine clinical outcome?
Kozek-Langenecker
Sibylle
S
Scharbert
Gila
G
D001780:Blood Coagulation Tests; D016063:Blood Loss, Surgical / Q000517:prevention & control*; D001803:Blood Transfusion; D003029:Coagulants / Q000008:administration & dosage; D005340:Fibrinogen / Q000008:administration & dosage; D005780:Gelatin / Q000008:administration & dosage; D006438:Hemodilution / Q000009:adverse effects; D006487:Hemostasis / Q000187:drug effects*; D006801:Humans; D006895:Hydroxyethyl Starch Derivatives / Q000008:administration & dosage; D007552:Isotonic Solutions / Q000008:administration & dosage; D019637:Orthopedic Procedures; D010952:Plasma Substitutes / Q000008:administration & dosage*; D000077325:Ringer's Lactate; D013916:Thrombelastography; D016896:Treatment Outcome
D003029:Coagulants; D006895:Hydroxyethyl Starch Derivatives; D007552:Isotonic Solutions; D010952:Plasma Substitutes; D000077325:Ringer's Lactate; D005780:Gelatin; D005340:Fibrinogen